Articles and Insights About Wearables for Clinical Trials

In May 2022, UCB launched a digital health roundtable series to explore the many diverse ways technology can benefit patients. In the third Roundtable, Emily Lewis (Digital Business Transformation, Neurology, UCB) convened an expert panel, including Dudley Tabakin, VivoSense CEO, to discuss the field of pediatric digital measurement to unpack key learnings from deployments to date, challenges, opportunities and the need for its translation into care. Watch the full video to hear insights from all four esteemed panelists.

Severe respiratory disease is one of the leading causes of infant illness and death worldwide. There is a significant upward trend of clinical infant respiratory studies, including the investigation into respiratory success in ventilated infants, SIDS, and neurological disorders that affect the normal respiratory pattern. In this article, we discuss how noninvasive respiratory monitoring and VivoSense^® software helps researchers collect and analyze respiratory data for clinical studies focused on infant and neo-natal breathing patterns.